Company: SYRA
Filing Date: 2025-03-11
Form Type: 10-K
Source: 0001493152-25-009873
Chunk: 215

Company: Syra Health Corp
Filing Date: 2025-03-11
Form: 10-K
Item: Item 1
Chunk 215
---
 152,887  
     184,904 
  
    Total current liabilities 
     613,549  
     910,072 

    Non-current portion of operating lease liability, related party 
     187,212  
     - 

    Total liabilities 
     800,761  
     910,072 

    Commitments and contingencies 
     -  
     - 

    Stockholders’ equity: 

    Preferred stock, $0.001 par value, 10,000,000 shares authorized, no shares designated, issued and outstanding 
     -  
     - 
  
    Class A common stock, $0.001 par value, 100,000,000 shares authorized, 8,979,204 and 5,588,298 shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively 
     8,979  
     5,588 
  
    Convertible class B common stock, $0.001 par value, 5,000,000 shares authorized, 833,334 shares issued and outstanding 
     833  
     833 
  
    Common stock, value 
     833  
     833 

    Additional paid-in capital 
     11,692,952  
     9,071,745 
  
    Accumulated deficit 
     (8,824,193) 
     (5,064,955)
  
    Total stockholders’ equity 
     2,878,571  
     4,013,211 

    Total liabilities and stockholders’ equity 
    $3,679,332  
    $4,923,283 

See
accompanying notes to audited financial statements.

F-3

SYRA
HEALTH CORP.

STATEMENTS
OF OPERATIONS

    2024  
    2023 

    For the Year Ended 

    2024  
    2023 

    Net revenues 
    $7,982,082  
    $5,515,144 
  
    Cost of services 
     6,329,119  
     4,103,244 
  
    Gross profit 
     1,652,963  
     1,411,900 

    Operating expenses: 

    Salaries and benefits